RFL
NYSE · Pharmaceuticals
Rafael Holdings Inc-Class B
$2.05
-0.01 (-0.49%)
Open$2.05
Previous Close$2.06
Day High$2.10
Day Low$1.95
52W High$3.96
52W Low$1.12
Volume—
Avg Volume111.4K
Market Cap107.14M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.64M | 1.26M | 15.20M |
| Net Income | -54,782,343 | -37,700,037 | 4.84M |
| Profit Margin | -3,328.2% | -3,161.8% | 31.9% |
| EBITDA | -51,825,190 | -37,646,375 | 7.34M |
| Free Cash Flow | — | — | 4.44M |
| Rev Growth | +30.8% | +30.8% | +5.7% |
| Debt/Equity | 0.01 | 0.01 | 0.33 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |